Allergan’s €1.7 Billion Registered Fixed and Floating Rate Notes Offering

Cravath represented the underwriters, led by Barclays, Goldman Sachs & Co. LLC, J.P. Morgan Securities, Morgan Stanley, BNP Paribas, Bank of America Merrill Lynch, Citigroup, HSBC, Mizuho Securities and Mitsubishi UFJ Financial Group, in connection with the €1.7 billion registered fixed and floating rate notes offering of Allergan Funding SCS, an indirect wholly owned subsidiary of Allergan plc, a global specialty pharmaceutical company. Application has been made to the New York Stock Exchange. The transaction closed on November 15, 2018.

The Cravath team included partner Andrew J. Pitts and associates Mark Mushkin, Douglas C. Dolan, Tyler J. Cook and Charles A. Dobb.